Plaunotol prevents the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats

Pharmacology

Volumn 74, Issue 4, 2005, Pages 182-192

  Ohta, Yoshiji ^a   Kamiya, Yoshio ^a   Imai, Yoichiro ^b   Arisawa, Tomiyasu ^a   Nakano, Hiroshi ^a  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Adherent gastric; Ascorbic acid; Compound 48 80; Gastric mucosal lesion (rat); Lipid peroxidation; Mucus; Neutrophil infiltration; Plaunotol; Se glutathione peroxidase

Indexed keywords

ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ASCORBIC ACID; COMPOUND 48-80; GLUTATHIONE PEROXIDASE; INDOMETACIN; LIPID; MYELOPEROXIDASE; PLAUNOTOL; PROSTAGLANDIN SYNTHASE INHIBITOR; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; ENZYME ACTIVITY; LIPID PEROXIDATION; MALE; MAST CELL DEGRANULATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; RAT; REACTION TIME; STOMACH MUCOSA INJURY;

ANIMALS; ANTI-ULCER AGENTS; ASCORBIC ACID; BLOOD FLOW VELOCITY; CELL DEGRANULATION; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ALCOHOLS; GASTRIC MUCOSA; GLUTATHIONE PEROXIDASE; HISTAMINE; INDOMETHACIN; MALE; MAST CELLS; MUCUS; P-METHOXY-N-METHYLPHENETHYLAMINE; PEROXIDASE; RATS; RATS, WISTAR; SELENIUM; SEROTONIN; SULFHYDRYL COMPOUNDS; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 22544457897     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085388     Document Type: Article

References (52)

1. Ogiso A, Kitazawa E, Kurabayashi M, Sato A, Takahashi S, Noguchi H, Kuwano H, Kobayashi S, Mishima H: Isolation and structure of antipeptic ulcer diterpene from Thai medical plant. Chem Pharm Bull (Tokyo) 1978;26:3117-3123.
2. Asaka M, Saito M, Miyazaki T, Ouchi Y, Miwa K, Kato M, Kosa S, Masaguri M, Mizukoshi M, Koike A: Clinical effect of CS-684 GML on gastritis. Jpn Pharmacol Ther 1990;18:149-159.
3. Maeda A, Tanaka Y, Tsuchiya M, Akimoto M, Ishiguro H, Hashimoto H, Niimi A, Hurihara T, Shigemoto M, Yamashita K, Yokoyama I: Endoscopic investigations of the prevention of NASID-induced gastric lesions. Especially, the usefulness of plaunotol. Prog Med 1998;18:2875-2879.
4. Kobayashi S, Ishibashi C, Mirota A, Masuda H, Ogiso A: Anti-ulcer activities of [(E,Z,E)7-hydroxymethyl-3,11,15′-trimethyl-2,6,10,14- hexadecatetraen-1-ol] (CS-684), a new acyclic diterpene alcohol from Thai medical plant, on experimental acute gastric and duodenal ulcers. Pharmacometrics 1982;24:599-607.
5. Okabe S, Tabata K, Kunimi H: Effects of [(E,Z,E)7-hydroxymethyl-3,11, 15′-trimethyl-2,6,10,14-hexadecatetraen-1-ol] on aspirin ulcers in rats and dogs. Pharmacometrics 1982;23:785-788.
6. Wada K, Kamisaka Y, Nakamoto K, Kishimoto Y, Ashida K, Itoh T: Effect of plaunotol on gastric injury induced by ischemia-reperfusion in rats. J Pharm Pharmacol 1997;49:903-907.
7. Murakami K, Okajima K, Harada N, Isobe H, Liu W, Johno M, Okabe H: Plaunotol prevents indomethacin-induced gastric mucosal injury in rats by inhibiting neutrophil activation. Aliment Pharmacol Ther 1999;13:521-530.
8. Kobayashi S, Mori M, Shimada Y, Endo K, Iwamoto M, Morita A, Ito T, Akiyama K: Facilitation of healing of the acetic acid-induced gastric ulcer by CS-684. Prog Med 1985;5(suppl 1):805-812.
9. Hawkey CJ, Rampton DS: Prostaglandins and the gastrointestinal mucosa: Are they important in its function, disease, or treatment? Gastroenterology 1985;89:1162-1188.
10. Wilson DE: Role of prostaglandins in gastroduodenal mucosal protection. J Clin Gastroenterol 1991;13(suppl 1):S65-S71.
11. Wallace JL, Tigley AW: New insights into prostaglandins and mucosal defense. Aliment Pharmacol Ther 1995;9:227-235.
12. Ushiyama S, Matsuda K, Asai F, Yamazaki M: Stimulation of prostaglandin production by (2E,6Z,10E)-7-hydroxymethyl-3,11,15-trimethyl-2,6,10,14- hexadecatetraen-1-ol (plaunotol), a new anti-ulcer drug in vitro and in vivo. Biochem Pharmacol 1987;36:369-375.
13. Okabe N, Okada M, Sakai T, Kuroiwa A: Effect of plaunotol on superoxide production activity in vivo. Dig Dis Sci 1995;40:2321-2322.
14. Usami E, Seyama Y: Evaluation of antiulceratives for superoxide scavenging activity. Jpn J Clin Chem 1995;24:170-174.
15. Usami E, Seyama Y, Watanabe S, Fukui T: Lipid radical-scavenging effect of antiulceratives. Jpn J Clin Chem 1996;25:229-234.
16. Enerback L, Lundin PM: Ulrastructure of mast cells in normal and compound 48/80-treated rats. Cell Tissue Res 1974;150:95-105.
17. Irman-Florjanc T, Erjavec F: Compound 48/80 and substance P induced release of histamine and serotonin from peritoneal mast cells. Agents Actions 1983;13:138-141.
18. Ohta Y, Kobayashi T, Nishida K, Ishiguro I: Relationship between changes of active oxygen metabolism and blood flow and formation, progression, and recovery of lesions in gastric mucosa of rats with a single treatment of compound 48/80, a mast cell degranulator. Dig Dis Sci 1997;42:1221-1232.
19. Ohta Y, Kobayashi T, Ishiguro I: Participation of xanthine-xanthine oxidase system and neutrophils in development of acute gastric mucosal lesions in rats with a single treatment of compound 48/80, a mast cell degranulator. Dig Dis Sci 1999;44:1865-1874.
20. Ohta Y, Kobayashi T, Ishiguro I: Role of endogenous serotonin and histamine in the pathogenesis of gastric mucosal lesions in unanesthetised rats with a single treatment of compound 48/80, a mast cell degranulator. Pharmacol Res 1999;39:261-267.
21. Ohta Y, Kamiya Y, Imai Y, Arisawa T, Nakano H: A change in gastric mucosal ascorbic acid status with the formation, progression, and recovery of compound 48/80-induced acute gastric mucosal lesions in rats. J Nutr Sci Vitaminol 2004;50:371-376.
22. Kamiya Y, Ohta Y, Imai Y, Arisawa T, Nakano H: A critical role of gastric mucosal ascorbic acid in the progression of acute gastric mucosal lesions induced by compound 48/80 in rats. World J Gastroenterol 2005;11:1324-1332.
23. Ohta Y, Kobayashi T, Inui K, Yoshino J, Nakazawa S: Protective effect of teprenone against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. J Pharmacol Sci 2003;93:337-346.
24. Ohta Y, Kobayashi T, Inui K, Yoshino J, Kitagawa A, Nakazawa S: Preventive effect of teprenone on acute gastric mucosal lesion progression in compound 48/80-treated rats. Eur J Pharmacol 2004;487:223-232.
25. Krawisz JE, Sharon P, Stenson WF: Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 1984;87:1344-1350.
26. Whittle BJR: Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981;80:94-98.
27. Suzuki K, Ota H, Sasagawa S, Sakatani T, Fujikura T: Assay method of myeloperoxidase in human polymorphonuclear leukocytes. Anal Biochem 1983;132:345-353.
28. Hochstein P, Utley H: Hydrogen peroxide detoxication by glutathione peroxidase and catalase in rat liver homogenates. Mol Pharmacol 1968;4:574-579.
29. Zannoni V, Lynch M, Goldstern S, Sato P: A rapid micromethod for the determination of ascorbic acid in plasma and tissues. Biochem Med 1974;11:41-48.
30. Sedlak J, Lindsay HR: Estimation of total, protein-bound, and non-protein sulfhydryl groups in tissue with Ellman's reagent. Anal Biochem 1968;25:192-205.
31. Ohkawa H, Ohishi N, Yagi K: Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-358.
32. Kitagawa H, Takada F, Kohei H: A simple method for estimation of gastric mucus and effects of antiulcerogenic agents on the decrease in mucus during water-immersion stress in rats. Arzneimitttelforschung 1986;36:1240-1244.
33. Shibata K, Onodera M, Kawada T and Iwai K: Simultaneous micro-determination of serotonin and 5-hydroxyindole-3-acetic acid with 5-hydroxy-Nω-methyltryptamine, as an internal standard in biological materials by high-performance liquid chromatography with electrochemical detection. J Chromatogr 1988; 430:381-387.
34. Lorenz W, Reimann H-J, Barth H, Kushe J, Meyer R, Doenicke A, Hutzel M: A sensitive and specific method for the determination of histamine in human whole blood and plasma. Hoppe Seylers Z Physiol Chem 1972;353:911-920.
35. Shore PA, Burkhalter A, Cohn VH Jr: A method for the fluorometric assay of histamine in tissue. J Pharmacol Exp Ther 1959;127:182-186.
36. Hogaboam CM, Bissoninette EY, Chin BC, Befus D, Wallace JL: Prostaglandins inhibit inflammatory mediator release from rat mast cells. Gastroenterology 1993;104:122-129.
37. Takeuchi K, Ohtsuki H, Okabe S: Pathogenesis of compound 48/80-induced gastric mucosal lesions in rats. Dig Dis Sci 1986;31:392-400.
38. Zimmerman JJ, Ciesielski W, Lewandoski J: Neutrophil-mediated phospholipid peroxidation assessed by gas chromatography-mass spectroscopy. Am J Physiol 1997;273:G653-G661.
39. Stelmaszynska T, Kukovetz E, Egger G, Schaur RJ: Possible involvement of myeloperoxidase in lipid peroxidation. Int J Biochem 1992; 24:121-128.
40. Kozol R, Kopatsis A, Fligiel SEG, Czanko R, Callewaert D: Neutrophil-mediated injury to gastric mucosal surface cells. Dig Dis Sci 1994;39:138-144.
41. Ohta Y, Kobayashi T, Inui K, Yoshino J, Nakazawa S: Protective effect of ebselen, a seleno-organic compound, against the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats. Jpn J Pharmacol 2002;90:295-303.
42. Lawrence RA, Burk RF: Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun 1976;71:952-958.
43. Rose RC, Bode AM: Biology of free radical scavengers: An evaluation of ascorbate. FASEB J 1993;7:1135-1142.
44. Jonas E, Dwenger A, Hager A: In vitro effect of ascorbic acid on neutrophil-dendotherial cell interaction. J Biolumin Chemilumin 1993;8:15-20.
45. Pigeolet E, Corbisier P, Houbion A, Lambert D, Michiels C, Raes M, Zachary MD, Remacle J: Glutathione peroxidase, superoxide dismutase, and catalase inactivation by peroxides and oxygen derived free radicals. Mech Ageing Dev 1990;51:283-297.
46. Sam S, Raha C, Chaterjee JB: Ascorbic acid as a scavenger of superoxide radical. Acta Vitaminol Enzymol 1983;5:234-240.
47. Boyd SC, Sasame HA, Boyd MR: High concentrations of glutathione in glandular stomach: Possible implications for carcinogenesis. Science 1979;205:1010-1012.
48. Stein HJ, Hinder RA, Oosthuizen MMJ: Gastric mucosal injury caused by hemorrhagic shock and reperfusion: Protective role of the antioxidant glutathione. Surgery 1990;108: 467-477.
49. Kanuitz JD: Barrier function of gastric mucus. Keio Med J 1999;48:63-68.
50. Grisham MB, Von Ritter C, Smith BF, LaMont JT, Granger DN: Interaction between oxygen radicals and gastric mucin. Am J Physiol 1987;253:G93-G96.
51. Seno K, Joh T, Yokoyama Y, Itoh M: Role of mucus in gastric mucosal injury induced by local ischemia/reperfusion. J Lab Clin Med 1995;126:287-293.
52. Ohta Y, Kobayashi T, Yoshino J, Nakazawa S: Effects of arachidonic acid metabolism-related enzyme inhibitors on compound 48/80-induced acute gastric mucosal lesions. Ulcer Res 2003;30:65-70.